Search
Displaying 11 - 20 of 2613 results for
QPP_COVID_SHMsummary
QPP Summary
SHM Buprenorphine Deregulation 2019 - Statement.pdf
The Society of Hospital Medicine supports the deregulation of buprenorphine to treat opioid use disorder. Buprenorphine is currently a Schedule III controlled substance but has restrictions